BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36562728)

  • 1. Glucometer Readout for Portable Detection of Heterogeneous Circulating Tumor Cells in Lung Cancer Captured on a Dual Aptamer Functionalized Wrinkled Cellulose Hydrogel Interface.
    Zuo Y; Lu W; Xia Y; Meng J; Zhou Y; Xiao Y; Zhu L; Liu D; Yang S; Sun Y; Li C; Yu Y
    ACS Sens; 2023 Jan; 8(1):187-196. PubMed ID: 36562728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer.
    Li C; Yang S; Li R; Gong S; Huang M; Sun Y; Xiong G; Wu D; Ji M; Chen Y; Gao C; Yu Y
    ACS Appl Mater Interfaces; 2022 Feb; 14(6):7646-7658. PubMed ID: 35104098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (CTCs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles.
    Wang Z; Sun N; Liu H; Chen C; Ding P; Yue X; Zou H; Xing C; Pei R
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39586-39593. PubMed ID: 31577122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cell Phenotype Detection and Epithelial-Mesenchymal Transition Tracking Based on Dual Biomarker Co-Recognition in an Integrated PDMS Chip.
    Xu H; Zuo Y; Gao S; Liu Y; Liu T; He S; Wang M; Hu L; Li C; Yu Y
    Small; 2024 May; ():e2310360. PubMed ID: 38698606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multifunctional black phosphorus nanosheet-based immunomagnetic bio-interface for heterogeneous circulating tumor cell capture and simultaneous self-identification in gastric cancer patients.
    Zuo Y; Xia Y; Lu W; Li Y; Xiao Y; Gao S; Zhou Z; Xu H; Feng X; Li C; Yu Y
    Nanoscale; 2023 Feb; 15(8):3872-3883. PubMed ID: 36722904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible capturing and voltammetric determination of circulating tumor cells using two-dimensional nanozyme based on PdMo decorated with gold nanoparticles and aptamer.
    Yang W; Fan L; Guo Z; Wu H; Chen J; Liu C; Yan Y; Ding S
    Mikrochim Acta; 2021 Sep; 188(10):319. PubMed ID: 34476628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of EpCAM and FRĪ± enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
    Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
    Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering Biomimetic Biosensor Using Dual-Targeting Multivalent Aptamer Regulated 3D DNA Walker Enables High-Performance Detection of Heterogeneous Circulating Tumor Cells.
    Jia L; Hu Q; Zhang T; Wang Z; Wu D; Xie X; Wang S
    Small; 2023 Sep; 19(38):e2302542. PubMed ID: 37222122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PLGA nanofiber microfluidic device for highly efficient isolation and release of different phenotypic circulating tumor cells based on dual aptamers.
    Wu Z; Pan Y; Wang Z; Ding P; Gao T; Li Q; Hu M; Zhu W; Pei R
    J Mater Chem B; 2021 Mar; 9(9):2212-2220. PubMed ID: 33616137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Biointerface Based on Cancer Cell Membranes for Specific Capture and Release of Circulating Tumor Cells.
    Ding P; Wang Z; Wu Z; Zhou Y; Sun N; Pei R
    ACS Appl Mater Interfaces; 2020 May; 12(18):20263-20270. PubMed ID: 32259427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
    Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
    Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
    Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
    PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Multivalent-Aptamer-Conjugated Nanoprobes for Superefficient Discerning of Single Circulating Tumor Cells in a Microfluidic Chip with Inductively Coupled Plasma Mass Spectrometry Detection.
    Zhang X; Wei X; Men X; Wu CX; Bai JJ; Li WT; Yang T; Chen ML; Wang JH
    ACS Appl Mater Interfaces; 2021 Sep; 13(36):43668-43675. PubMed ID: 34473482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greatly Enhanced CTC Culture Enabled by Capturing CTC Heterogeneity Using a PEGylated PDMS-Titanium-Gold Electromicrofluidic Device with Glutathione-Controlled Gentle Cell Release.
    Kwizera EA; Ou W; Lee S; Stewart S; Shamul JG; Xu J; Tait N; Tkaczuk KHR; He X
    ACS Nano; 2022 Jul; 16(7):11374-11391. PubMed ID: 35797466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Hydrogel with Aptamer-Toehold-Based Recognition, Cloaking, and Decloaking of Circulating Tumor Cells for Live Cell Analysis.
    Song P; Ye D; Zuo X; Li J; Wang J; Liu H; Hwang MT; Chao J; Su S; Wang L; Shi J; Wang L; Huang W; Lal R; Fan C
    Nano Lett; 2017 Sep; 17(9):5193-5198. PubMed ID: 28771008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1.
    Schehr JL; Schultz ZD; Warrick JW; Guckenberger DJ; Pezzi HM; Sperger JM; Heninger E; Saeed A; Leal T; Mattox K; Traynor AM; Campbell TC; Berry SM; Beebe DJ; Lang JM
    PLoS One; 2016; 11(7):e0159397. PubMed ID: 27459545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway.
    Liao ZJ; Guo YH; Zhao Z; Yao JT; Xu R; Nan KJ
    Int J Oncol; 2014 Aug; 45(2):651-8. PubMed ID: 24867356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a Biocompatible and Ratiometric Fluorescent probe for the Capture, Detection, Release, and Reculture of Rare Number CTCs.
    Yu Y; Yang Y; Ding J; Meng S; Li C; Yin X
    Anal Chem; 2018 Nov; 90(22):13290-13298. PubMed ID: 30345741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective capture of circulating tumor cells by antifouling nanostructure substrate made of hydrogel nanoparticles.
    Wang Z; Wu Z; Ding P; Sun N; Feng S; Xing C; Zou H; Pei R
    Colloids Surf B Biointerfaces; 2021 Jun; 202():111669. PubMed ID: 33690063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.